DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/4lntp8/a_product_and) has announced the addition of the "A Product and Pipeline Analysis of the Lung Cancer Therapeutics Market" report to their offering.
This study assesses marketed and in-research products and combination regimens for the lung cancer therapeutics market. Segmentation by drug class is provided, along with additional supporting information such as clinical trial timelines and results, historical and projected launch timelines, and epidemiology. The marketed and pipeline products are broadly segmented by their mechanism of action against cancer. Cost-effective treatments and targeted therapies are the key unmet needs of the market.
Key Topics Covered:
1. Executive Summary
2. Methodology and Scope
3. Market Overview
5. Competitive Landscape
6. Marketed Products
7. Pipeline Drugs Analysis
8. Product Dashboard of Recently Approved Drugs and Late-stage Pipeline Drug Candidates
11. The Story
For more information visit http://www.researchandmarkets.com/research/4lntp8/a_product_and